Trial intelligence / Profile preview

STATIN-PRE trial

2024-519853-12-00Phase 3Authorised

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in preeclampsia, intrauterine growth restriction (IUGR) and placental insufficiency comparing Pravastatin arm with Placebo arm (2 arms). Primary endpoint: Days of prolongation of pregnancy between inclusion and delivery. Planned start Jun 2025; status: authorised.

02

Drugs

pravastatin
03

Conditions

preeclampsiaintrauterine growth restriction (IUGR)placental insufficiency

Beyond the preview

Go deeper on 2024-519853-12-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-519853-12-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call